Alexander Rothman, PhD, on the Effects of IL-1 Inhibition With Canakinumab on BP and Hypertension
In this podcast, Alexander Rothman, MD, PhD, discusses his team's latest analysis of CANTOS, which\xa0evaluated\xa0whether interleukin-1\u03b2 inhibition would reduce blood pressure, prevent incident hypertension, and modify relationships between hypertension and cardiovascular events. More at: www.consultant360.com/cardiology.